2022 ETA指南：儿童 Graves'病的管理

2022-01-01 欧洲甲状腺协会 Eur Thyroid J

2022年1月，欧洲甲状腺协会(ETA)发布了儿童 Graves'病的管理指南。

中文标题：

英文标题：

2022 European Thyroid Association Guideline for the management of pediatric Graves' disease

发布机构：

欧洲甲状腺协会

发布日期：

2022-01-01

简要介绍：

2022年1月，欧洲甲状腺协会(ETA)发布了儿童 Graves'病的管理指南。由Graves'病引起的甲亢在儿童中相对罕见，其治疗方案与成人相关，包括抗甲状腺药物（ATD）、放射性碘（RAI）或甲状腺手术。本文主要针对儿童 Graves'病的管理提供指导建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=0c81d1c00231151b, title=2022 ETA指南：儿童 Graves'病的管理, enTitle=2022 European Thyroid Association Guideline for the management of pediatric Graves' disease, guiderFrom=Eur Thyroid J, authorId=0, author=, summary=2022年1月，欧洲甲状腺协会(ETA)发布了儿童 Graves'病的管理指南。, cover=https://img.medsci.cn/202215/1641360668508_1608702.png, journalId=0, articlesId=null, associationId=483, associationName=欧洲甲状腺协会, associationIntro=欧洲甲状腺协会（European Thyroid Association ETA)成立于1965年，此后每年定期举行一次国际甲状腺会议，会员资格等级分为荣誉会员、普通会员、初级会员、团体会员、合作会员、高级会员六类，目前有600余名会员。旨在推动甲状腺学（基础和临床）及甲状腺病学的发展。, copyright=0, guiderPublishedTime=Sat Jan 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年1月，欧洲甲状腺协会(ETA)发布了儿童 Graves'病的管理指南。由Graves'病引起的甲亢在儿童中相对罕见，其治疗方案与成人相关，包括抗甲状腺药物（ATD）、放射性碘（RAI）或甲状腺手术。本文主要针对儿童 Graves'病的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=736, tagName=甲状腺), TagDto(tagId=120875, tagName= 毒性弥漫性甲状腺肿)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5443, appHits=102, showAppHits=0, pcHits=535, showPcHits=5338, likes=1, shares=9, comments=6, approvalStatus=1, publishedTime=Wed Jan 05 13:27:27 CST 2022, publishedTimeString=2022-01-01, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Wed Jan 05 13:31:54 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 10:37:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ETA指南：儿童+Graves'病的管理.pdf)])

2022 ETA指南：儿童+Graves'病的管理.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1202401, encodeId=7b361202401b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/e633ce4f3ddf4648bd8b9ea53f327fa5/bdddb5ec4681419eb54d5cb0db0eb53d.jpg, createdBy=20cc5475034, createdName=一名医生👩‍⚕️, createdTime=Mon Mar 14 10:16:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197450, encodeId=90ce119e45011, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Sat Feb 26 11:46:43 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187884, encodeId=844f118e884f0, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Tue Jan 25 02:47:48 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185445, encodeId=c5d4118544526, content=👍👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:36:30 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-03-14 一名医生👩‍⚕️

很好

67 0
[GetPortalCommentsPageByObjectIdResponse(id=1202401, encodeId=7b361202401b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/e633ce4f3ddf4648bd8b9ea53f327fa5/bdddb5ec4681419eb54d5cb0db0eb53d.jpg, createdBy=20cc5475034, createdName=一名医生👩‍⚕️, createdTime=Mon Mar 14 10:16:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197450, encodeId=90ce119e45011, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Sat Feb 26 11:46:43 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187884, encodeId=844f118e884f0, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Tue Jan 25 02:47:48 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185445, encodeId=c5d4118544526, content=👍👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:36:30 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-02-26 ms7000001680568286

学到了

66 0
[GetPortalCommentsPageByObjectIdResponse(id=1202401, encodeId=7b361202401b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/e633ce4f3ddf4648bd8b9ea53f327fa5/bdddb5ec4681419eb54d5cb0db0eb53d.jpg, createdBy=20cc5475034, createdName=一名医生👩‍⚕️, createdTime=Mon Mar 14 10:16:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197450, encodeId=90ce119e45011, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Sat Feb 26 11:46:43 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187884, encodeId=844f118e884f0, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Tue Jan 25 02:47:48 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185445, encodeId=c5d4118544526, content=👍👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:36:30 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-01-25 283488816

太好了

61 0
[GetPortalCommentsPageByObjectIdResponse(id=1202401, encodeId=7b361202401b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/e633ce4f3ddf4648bd8b9ea53f327fa5/bdddb5ec4681419eb54d5cb0db0eb53d.jpg, createdBy=20cc5475034, createdName=一名医生👩‍⚕️, createdTime=Mon Mar 14 10:16:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197450, encodeId=90ce119e45011, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Sat Feb 26 11:46:43 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187884, encodeId=844f118e884f0, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Tue Jan 25 02:47:48 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185445, encodeId=c5d4118544526, content=👍👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:36:30 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-01-18 ms6000000807686529

👍👍👍👍

64 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

内分泌指南

2022 ETA指南：儿童 Graves'病的管理

相关指南

科室

工具

服务